[Fundamental and clinical evaluations of cefmenoxime in the field of pediatrics].
D000367:Age Factors; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D015281:Cefmenoxime; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008297:Male; D008581:Meningitis / Q000134:cerebrospinal fluid; D011817:Rabbits; D013203:Staphylococcal Infections / Q000134:cerebrospinal fluid
D015281:Cefmenoxime; D002439:Cefotaxime